A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection (Q34542427)

2 August 2017

title

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection (English)

1 reference

randomized controlled trial

2 August 2017

main subject

Orthoebolavirus zairense

0 references

1 reference

4

Lori Dodd

0 references

Anthony Fauci

12

object named as

Anthony S Fauci

1 reference

2 August 2017

John Beigel

9

0 references

H. Clifford Lane

11

object named as

H Clifford Lane

1 reference

2 August 2017

15

0 references

Nahid Bhadelia

1 reference

ORCID Public Data File 2021

Michael Proschan

5

object named as

Michael A Proschan

1 reference

2 August 2017

3

Richard T Davey

1 reference

2 August 2017

6

James Neaton

1 reference

2 August 2017

author name string

PREVAIL II Writing Group

1

1 reference

2 August 2017

Multi-National PREVAIL II Study Team

2

1 reference

2 August 2017

Jacquie Neuhaus Nordwall

7

1 reference

2 August 2017

Joseph S Koopmeiners

8

1 reference

2 August 2017

John Tierney

10

1 reference

2 August 2017

Moses B F Massaquoi

13

1 reference

2 August 2017

Foday Sahr

14

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 2016

1 reference

The New England Journal of Medicine

2 August 2017

published in

1 reference

2 August 2017

volume

375

1 reference

2 August 2017

issue

15

1 reference

2 August 2017

page(s)

1448-1456

1 reference

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Prognostic Indicators for Ebola Patient Survival

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Statistical considerations for a trial of Ebola virus disease therapeutics

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Evaluating interventions for Ebola: The need for randomized trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Trial design for evaluating novel treatments during an outbreak of an infectious disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Blood kinetics of Ebola virus in survivors and nonsurvivors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Ebola viral load at diagnosis associates with patient outcome and outbreak evolution

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Clinical presentation, biochemical, and haematological parameters and their association with outcome in patients with Ebola virus disease: an observational cohort study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Médecins Sans Frontières Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Ebola virus (EBOV) infection: Therapeutic strategies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Evaluating Ebola therapies--the case for RCTs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Ebola in west Africa: from disease outbreak to humanitarian crisis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Ebola haemorrhagic fever in Zaire, 1976

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

INFECTIOUS DISEASE. As Ebola epidemic draws to a close, a thin scientific harvest

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

Drug assessment in the Ebola virus disease epidemic in West Africa

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086427

27 October 2018

Identifiers

DOI

10.1056/NEJMOA1604330

1 reference

2 August 2017

1 reference

2 August 2017

1 reference